Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/09/2010 → 31/08/2013 |
Efficacy of Adalimumab treatment to prolong the partial remission period and induce immune regulation in patients with newly diagnosed type 1 diabetes.
- Gnudi, Luigi (Primary Investigator)
- Gulliford, Martin (Primary Investigator)
- Mirenda, Vincenzo (Primary Investigator)
Project: Research